We are involved in exploring new indications for molecules with the goal of developing innovative therapies to improve patient healthcare. Currently, Pharmaceutical Innovation Services, S.L. is sponsoring two groundbreaking projects that are investigating new molecules for treating conditions with no effective therapies, including Spinal Cord Injury, post-COVID fatigue, and certain symptoms of Parkinson’s disease. We are collaborating with companies like Sinfatín and Golden Gait Biotech to carry out these projects.
